Virgin Galactic's Space Tourism Resumes and Twilio Surges: Key Moves Across Uncategorized US StocksGlobal Report·20 hours agoSPCE-0.34%GSUN-8.28%
Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs | APRE Stock NewsStockTitan·Aug 28 at 04:15 AMAPRE+4.46%
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga_article·Aug 27 at 05:06 PMAPUS-8.76%PPCB-16.30%
The Market's Hidden Corners: From Copper Mines to AI Assembly, the Overlooked US NarrativesGlobal Report·Aug 25 at 10:12 AMMAT-2.41%APRE+4.46%
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga_article·Aug 24 at 05:06 PMLUCYW-12.67%PMI-54.37%
Aprea Therapeutics advances APR-1051 oncology pipeline progressTip Ranks·Aug 12 at 12:58 PMAPRE+4.46%
Aprea Therapeutics | 8-K: FY2026 Q2 Revenue Misses Estimate at USD 0Earnings Watch·Aug 12 at 12:37 PMAPRE+4.46%
Aprea Therapeutics: Buy Rating Reiterated as APR-1051 Clinical Momentum Builds; $1.20 Price Target MaintainedTip Ranks·Aug 10 at 04:25 PMAPRE+4.46%
Aprea Therapeutics targets Q4 2026 clinical data readout for APR-1051 Phase 1 ACESOT-1051 trialPUBT·Jul 30 at 12:10 PMAPRE+4.46%
Aprea Therapeutics gets Nasdaq extension to regain $1 minimum bid price compliancePUBT·Jul 23 at 08:27 PMAPRE+4.46%
